Wednesday, October 20, 2021

Crescendo Biologics expands Takeda collaboration

Cambridge, UK-based Crescendo Biologics will expand its discovery and development collaboration with Takeda focused on building Humabody-based therapeutics against undisclosed targets.

The expanded collaboration comes following Crescendo’s achievement of its sixth technical milestone within the original collaboration agreement.

The expansion will enable Takeda to access a range of Crescendo’s half-life extension Humabodies for use with its two Humabody programmes, licensed in November 2018 and July 2019.

Crescendo added in a statement that it has successfully delivered novel oncology targeted Humabody lead molecules using its in-house discovery process.

Crescendo describes its Humabody products as ‘a novel class of small, robust and potent protein therapeutics based on fully human VH domain building blocks’.

Compared to full antibodies, Humabodies have differentiated pharmacological properties: they are small and can rapidly penetrate and accumulate in tissue/tumours whilst clearing quickly from circulation to minimise systemic toxicity, it said.

“Crescendo has again demonstrated its ability to deliver differentiated Humabody molecules against specific targets selected by Takeda, on schedule. The expansion of our collaboration, together with the achievement of this sixth milestone, further validates the excellent work being done at Crescendo to progress the next generation of differentiated cancer therapies,” said Theodora Harold, chief executive officer of Crescendo.

“Our fruitful collaboration with Crescendo continues to show great progress. We are delighted to expand our work together, drawing on Takeda’s vast oncology drug discovery experience and Crescendo’s expertise in developing optimally constructed Humabody molecules to quickly advance novel therapeutics with transformative treatment potential towards the clinic,” added Loïc Vincent, Head, Oncology Drug Discovery Unit, Takeda.

Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...